Carlsmed (CARL) Invested Capital (2025 - 2026)

Carlsmed's (CARL) quarterly Invested Capital came in at $15.6 million in Q1 2026, little changed on a QoQ basis from $15.6 million in Q4 2025.

Carlsmed (CARL) Invested Capital (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has 2 years of Invested Capital data on file, last reported at $15.6 million in Q1 2026.

Quarterly Invested Capital changed N/A year-over-year to $15.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.5 million (changed N/A YoY) and the FY2025 annual result came in at $15.6 million, changed N/A from the prior year.
Invested Capital steadied at $15.6 million in Q1 2026, from $15.6 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $15.6 million in Q2 2025 to a low of $15.6 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	41.45 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	14.19 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Carlsmed	389.87 Mn	276.57 Mn	14.54 Mn	15.63 Mn

Download Data